关于“低风险去势抵抗性前列腺癌患者睾酮替代治疗的随机1期研究”的编辑评论 - Suppr

Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.

van der Poel Henk G

Eur Urol. 2009 Jul;56(1):103-4. doi: 10.1016/j.eururo.2009.02.023. Epub 2009 Feb 27.

Abstract

摘要

Eur Urol. 2009 Jul;56(1):103-4. doi: 10.1016/j.eururo.2009.02.023. Epub 2009 Feb 27.

Eur Urol. 2009 Nov;56(5):e36; author reply e37. doi: 10.1016/j.eururo.2009.07.052. Epub 2009 Aug 12.

Urologiia. 2008 May-Jun(3):57-8, 60-2.

Eur Urol. 2004 Sep;46(3):285-94; discussion 294-5. doi: 10.1016/j.eururo.2004.04.012.

Scand J Urol Nephrol. 2005;39(1):87-8. doi: 10.1080/00365590410002546.

Eur Urol. 2010 Feb;57(2):e18-9; author reply e20. doi: 10.1016/j.eururo.2009.10.021. Epub 2009 Oct 20.

Can J Urol. 2006 Feb;13 Suppl 1:40-3.

Eur Urol. 2009 Feb;55(2):321. doi: 10.1016/j.eururo.2008.09.026. Epub 2008 Sep 24.

Br J Cancer. 1999 Jan;79(1):146-55. doi: 10.1038/sj.bjc.6690024.

Maturitas. 2009 Jul 20;63(3):213-9. doi: 10.1016/j.maturitas.2009.04.008. Epub 2009 May 31.

Int Braz J Urol. 2022 Jan-Feb;48(1):188-195. doi: 10.1590/S1677-5538.IBJU.2022.01.08.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。